Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor We agree with Dr Ebrahim and colleagues1 that reanalyses of clinical trial data provide an important opportunity to better understand trial results and that more independent reanalyses are needed. However, the estimate of the number of reanalyses published prior to March 9, 2014, reported by Ebrahim et al1 is incorrect, possibly by a substantial margin.
Platts-Mills TF, Jones CW. Reanalyses of Trial Results. JAMA. 2015;313(1):92-93. doi:10.1001/jama.2014.15627